Andere Sprachen Humanigen, Inc.

Aktien

Markt geschlossen - OTC Markets Andere Börsenplätze 20:17:24 23.04.2024			% 5 Tage	% 1. Jan.
0,0067 ^USD	+669.900,00 %		0,00 %	+458,33 %

05.01.	Humanigen, Entwickler der 19-Behandlung, meldet Konkurs nach Chapter 11 an	RE
03.01.	Humanigen, Inc. stellte einen Konkursantrag	CI

Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	12.04.
Final DIP Financing Approved for Humanigen, Inc.	08.03.
Motion for Asset Sale Approved for Humanigen, Inc.	17.02.
Notice for Auction Cancellation Filed by Humanigen, Inc.	13.02.
Bidding Procedure Approved for Humanigen, Inc.	25.01.
News Highlights : Top Company News of the Day	05.01.
19 treatment developer Humanigen files for Chapter 11 bankruptcy	05.01.
Motion for Asset Sale Filed by Humanigen, Inc.	04.01.
Humanigen, Inc. Filed for Bankruptcy	03.01.
Interim DIP Financing Approved for Humanigen, Inc.	03.01.
Xspray Pharma Names Chief Commercial Officer	15.09.23
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	14.09.23
North American Morning Briefing : PCE Inflation -2-	31.08.23
North American Morning Briefing : Nasdaq Futures -2-	24.08.23
CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)	09.08.23
Humanigen, Inc.(OTCPK:HGEN) dropped from S&P TMI Index	28.07.23
Sector Update: Health Care Stocks Steady in Late Afternoon Trading	25.07.23
Sector Update: Health Care Stocks Steady Tuesday Afternoon	25.07.23
Sector Update: Health Care	25.07.23
Humanigen Issues 'Going Concern' Warning; Shares Hit 52-Week Low	25.07.23

Keine Ergebnisse zu dieser Suche